Australia - English - Department of Health (Therapeutic Goods Administration)

lima orthopaedics australia pty ltd - 34190 - uncoated hip femur prosthesis, modular - the friendly uncoated 12/14 morse taper femoral stem is made of of fecrnimnmonbn stainless steel for enhanced strength and corrosion resistant. it is coupled together with an femoral neck. it is for cemented use. the friendly femoral stem is a part of a partial or total hip arthroplasty intended to reduce pain and give articular mobility to the patient.

Australia - English - Department of Health (Therapeutic Goods Administration)

sunlife products pty ltd - butyl methoxydibenzoylmethane, quantity: 50 mg/g; 4-methylbenzylidene camphor, quantity: 40 mg/g; octocrylene, quantity: 20 mg/g; bemotrizinol, quantity: 5 mg/g - spray - excipient ingredients: purified water; phenoxyethanol; ethyl hydroxybenzoate; propyl hydroxybenzoate; methyl hydroxybenzoate; dl-alpha-tocopheryl acetate; trolamine; alkyl (c12-15) benzoate; dipropylene glycol dibenzoate; ppg-15 stearyl ether benzoate; disodium edetate; white beeswax; peg-40 stearate; isopropyl palmitate; peg-15 cocamine; butylated hydroxytoluene; acrylates/c10-30 alkyl acrylate crosspolymer; cetyl dimeticone; cocoglycerides; 1,3-butylene glycol - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

friendly ag-products pty ltd - neem seed extract powder - unknown - neem seed extract powder extract-plant active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

friendly ag-products pty ltd - azadiractin a & b - insecticide - cotton - eastern false wireworm | false wireworm (larvae) gonocephalum mac | false wireworm

Australia - English - Department of Health (Therapeutic Goods Administration)

sunlife products pty ltd - 4-methylbenzylidene camphor,butyl methoxydibenzoylmethane,homosalate,octyl salicylate,octocrylene -

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - lactobacillus plantarum, quantity: 1 billion cfu; saccharomyces cerevisiae (boulardii), quantity: 1 billion cfu; lactobacillus acidophilus, quantity: 1 billion cfu; bifidobacterium longum, quantity: 1 billion cfu; lactobacillus rhamnosus, quantity: 1 billion cfu; bifidobacterium breve, quantity: 1 billion cfu; lactobacillus casei, quantity: 1 billion cfu; bifidobacterium lactis, quantity: 1 billion cfu - capsule, hard - excipient ingredients: colloidal anhydrous silica; purified water; magnesium stearate; hypromellose; microcrystalline cellulose; maltodextrin; sorbitan monostearate - maintain/support general health and wellbeing ; decrease/reduce/relieve bowel discomfort ; decrease/reduce/relieve flatulence/carminative ; maintain/support healthy digestive system function ; maintain/support digestive system health ; maintain/support intestinal good/beneficial/friendly flora ; helps maintain/support good/beneficial/friendly gut flora during antibiotic use ; help restore good/beneficial/friendly gut flora after antibiotic use ; maintain/support gastrointestinal system health ; decrease/reduce/relieve abdominal bloating/distention ; maintain/support immune system health ; maintain/support healthy immune system function

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - lactobacillus casei, quantity: 1.25 billion cfu; bifidobacterium breve, quantity: 0.5 billion cfu; lactobacillus plantarum, quantity: 7 billion cfu; lactobacillus salivarius ssp salivarius, quantity: 1.25 billion cfu; lactobacillus rhamnosus, quantity: 2 billion cfu; bifidobacterium lactis, quantity: 14 billion cfu; lactobacillus paracasei, quantity: 14.8 billion cfu; bifidobacterium lactis, quantity: 4 billion cfu; bifidobacterium longum, quantity: 0.5 billion cfu; lactobacillus gasseri, quantity: 0.1 bill - capsule, hard - excipient ingredients: microcrystalline cellulose; maltodextrin; colloidal anhydrous silica; magnesium stearate; hypromellose; gellan gum - maintain/support general health and wellbeing ; decrease/reduce/relieve constipation ; decrease/reduce/relieve bowel discomfort ; decrease/reduce/relieve flatulence/carminative ; helps enhance/improve/promote/increase intestinal transit time ; maintain/support healthy digestive system function ; aid/assist digestion of lactose ; maintain/support digestive system health ; maintain/support intestinal good/beneficial/friendly flora ; helps maintain/support good/beneficial/friendly gut flora during antibiotic use ; help restore good/beneficial/friendly gut flora after antibiotic use ; maintain/support gastrointestinal system health ; decrease/reduce/relieve abdominal bloating/distention ; maintain/support immune system health ; maintain/support healthy immune system function

Australia - English - Department of Health (Therapeutic Goods Administration)

mcpherson's consumer products pty ltd - streptococcus thermophilus, quantity: 0.5 billion cfu; bifidobacterium lactis, quantity: 14 billion cfu; lactobacillus rhamnosus, quantity: 2 billion cfu; lactobacillus salivarius ssp salivarius, quantity: 1.25 billion cfu; lactobacillus casei, quantity: 1.25 billion cfu; lactobacillus acidophilus, quantity: 12 billion cfu; lactobacillus plantarum, quantity: 7 billion cfu; lactobacillus gasseri, quantity: 0.1 billion cfu; bifidobacterium breve, quantity: 0.5 billion cfu; bifidobacterium longum, quantity: 0. - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; maltodextrin; colloidal anhydrous silica; hypromellose; gellan gum - maintain/support general health and wellbeing ; decrease/reduce/relieve constipation ; decrease/reduce/relieve bowel discomfort ; decrease/reduce/relieve flatulence/carminative ; helps enhance/improve/promote/increase intestinal transit time ; maintain/support healthy digestive system function ; aid/assist digestion of lactose ; maintain/support digestive system health ; maintain/support intestinal good/beneficial/friendly flora ; helps maintain/support good/beneficial/friendly gut flora during antibiotic use ; help restore good/beneficial/friendly gut flora after antibiotic use ; maintain/support gastrointestinal system health ; decrease/reduce/relieve abdominal bloating/distention ; maintain/support immune system health ; maintain/support healthy immune system function

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - paroxetine hydrochloride, quantity: 22.2 mg - tablet, film coated - excipient ingredients: mannitol; titanium dioxide; magnesium stearate; copovidone; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; sodium starch glycollate; purified talc - paroxetine gh is indicated for the treatment of : - major depression and for the prevention of relapse of depressive symptoms - obsessive compulsive disorder (ocd) and prevention of relapse of ocd - panic disorder and for the prevention of relapse of panic disorder - social anxiety disorder/social phobia - general anxiety disorder - post-traumatic stress disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder